Try it
Pharmacology · Anticancer drugs
Sample itemWhat is a major dose-limiting toxicity of many cytotoxic anticancer drugs?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Myelosuppression
The key Anticancer drugs principle identifies Myelosuppression as the best answer because it most directly accounts for the mechanism, use, or laboratory finding described.
Option by option
A. Myelosuppression (correct)
Correct. Myelosuppression matches the decisive principle in this item.
B. Improved immune response
Improved immune response does not fit the stated anticancer drugs relationship.
C. Hypertension only
Hypertension only may have another clinical role but is not supported by this clue.
D. Dental enamel growth
Dental enamel growth is inconsistent with the requested mechanism or identification.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Anticancer drugsA patient receiving high-dose methotrexate for osteosarcoma develops severe mucositis an…
- Anticancer drugsWhy is methotrexate toxicity increased by trimethoprim?
- Anticancer drugsWhat is a major toxicity of cisplatin?
- Anticancer drugsWhy is folinic acid used after high-dose methotrexate?